Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) - Equities research analysts at Atb Cap Markets decreased their Q3 2025 earnings estimates for shares of Aurora Cannabis in a research note issued on Monday, December 16th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings per share of ($0.13) for the quarter, down from their prior forecast of ($0.09). The consensus estimate for Aurora Cannabis' current full-year earnings is ($0.02) per share. Atb Cap Markets also issued estimates for Aurora Cannabis' Q4 2025 earnings at ($0.10) EPS, FY2025 earnings at ($0.10) EPS, FY2026 earnings at ($0.16) EPS, FY2027 earnings at ($0.01) EPS and FY2029 earnings at $0.40 EPS.
A number of other research firms also recently issued reports on ACB. TD Securities raised shares of Aurora Cannabis to a "strong-buy" rating in a research note on Thursday, December 12th. TD Cowen assumed coverage on Aurora Cannabis in a research note on Wednesday, December 11th. They issued a "buy" rating on the stock.
Get Our Latest Analysis on Aurora Cannabis
Aurora Cannabis Trading Down 3.3 %
Shares of Aurora Cannabis stock traded down $0.14 during midday trading on Thursday, reaching $4.10. 663,278 shares of the company's stock traded hands, compared to its average volume of 2,831,022. The company has a market cap of $224.86 million, a PE ratio of -5.39 and a beta of 1.86. The stock has a 50 day moving average of $4.91 and a 200-day moving average of $5.48. Aurora Cannabis has a 12 month low of $2.84 and a 12 month high of $9.35. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83.
Institutional Investors Weigh In On Aurora Cannabis
Several hedge funds have recently bought and sold shares of ACB. Cubist Systematic Strategies LLC purchased a new position in shares of Aurora Cannabis during the second quarter valued at approximately $50,000. Toronto Dominion Bank raised its holdings in Aurora Cannabis by 34,356.4% in the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company's stock worth $88,000 after buying an additional 18,896 shares during the last quarter. Mackenzie Financial Corp bought a new position in shares of Aurora Cannabis in the second quarter worth approximately $113,000. TD Asset Management Inc purchased a new stake in shares of Aurora Cannabis during the second quarter valued at approximately $255,000. Finally, Headlands Technologies LLC raised its holdings in Aurora Cannabis by 98.8% in the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company's stock worth $346,000 after acquiring an additional 37,269 shares during the last quarter. Institutional investors own 47.63% of the company's stock.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
